Literature DB >> 21913016

High serum hyaluronic acid and HBV viral load are main prognostic factors of local recurrence after complete radiofrequency ablation of hepatitis B-related small hepatocellular carcinoma.

Feng Xia1, Eric C H Lai, Wan-Yee Lau, Kuansheng Ma, Xiaowu Li, Ping Bie, Cheng Qian.   

Abstract

PURPOSE: The risk factors of local recurrence after complete radiofrequency ablation (RFA) of hepatitis B-related small hepatocellular carcinoma (HCC), ≤3 cm, remains to be clarified. In this study, we evaluated the potential prognostic factors that affect recurrence.
METHODS: A total of 152 consecutive patients with small HCC who had undergone complete RFA were retrospectively studied. The risk factors of local recurrence and their impact on survivals of patients were analyzed.
RESULTS: After a median follow-up of 35 months, intrahepatic recurrence occurred in 67 patients (44.1%). On univariate analysis, HBV DNA, hyaluronic acid, AFP, MELD score, and precollagen III were independent risk factors for recurrence. On multivariate analysis, HBV DNA and hyaluronic acid were independent risk factors for recurrence. The cumulative 1-, 3-, and 5-year disease-free survival rates were 86.8%, 41.2%, and 22.8% in the high viral load group and 96.4%, 65.8%, and 36.7% in the low viral load group, respectively. The difference between the two groups was significant (P=0.003). The cumulative 1-, 3-, and 5-year disease-free survival rates were 87.2%, 42%, and 27.2% in the abnormal hyaluronic acid group and 94.9%, 63.5%, and 33.9% in the normal group, respectively. The difference between the two groups also was significant (P=0.011). Multivariate analysis identified MELD score as the only independent risk factor for overall survival of all patients.
CONCLUSIONS: High serum hyaluronic acid and HBV viral load are main prognostic factors of local recurrence after complete radiofrequency ablation of hepatitis B-related small HCC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21913016     DOI: 10.1245/s10434-011-2042-3

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  13 in total

Review 1.  Predicting recurrence following radiofrequency percutaneous ablation for hepatocellular carcinoma.

Authors:  Nathalie Ganne-Carrié; Jean-Charles Nault; Marianne Ziol; Gisèle N'Kontchou; Pierre Nahon; Véronique Grando; Valérie Bourcier; Sandrine Barge; Michel Beaugrand; Jean-Claude Trinchet; Olivier Seror
Journal:  Hepat Oncol       Date:  2014-12-11

2.  Local tumour progression after ultrasound-guided microwave ablation of liver malignancies: risk factors analysis of 2529 tumours.

Authors:  Jie Yu; Ping Liang; Xiao-Ling Yu; Zhi-Gang Cheng; Zhi-Yu Han; Meng-Juan Mu; Qin-Ying Li; Yan-Mei Liu
Journal:  Eur Radiol       Date:  2014-11-19       Impact factor: 5.315

Review 3.  Individualized Ablation of Hepatocellular Carcinoma: Tailored Approaches across the Phenotype Spectrum.

Authors:  Zlatko Devcic; Mohamed Elboraey; Lucas Vidal; Kabir Mody; Denise Harnois; Tushar Patel; Beau B Toskich
Journal:  Semin Intervent Radiol       Date:  2019-10-31       Impact factor: 1.513

Review 4.  Anti-viral therapy to reduce recurrence and improve survival in hepatitis B virus-related hepatocellular carcinoma.

Authors:  Toru Ishikawa
Journal:  World J Gastroenterol       Date:  2013-12-21       Impact factor: 5.742

5.  Effects of antiviral therapy on the recurrence of hepatocellular carcinoma after curative resection or liver transplantation.

Authors:  Yan Du; Tong Su; Yibo Ding; Guangwen Cao
Journal:  Hepat Mon       Date:  2012-10-20       Impact factor: 0.660

6.  Prognostic factors in patients with hepatitis B virus-related hepatocellular carcinoma undergoing nucleoside analog antiviral therapy.

Authors:  Hiroki Nishikawa; Norihiro Nishijima; Akira Arimoto; Tadashi Inuzuka; Ryuichi Kita; Toru Kimura; Yukio Osaki
Journal:  Oncol Lett       Date:  2013-09-12       Impact factor: 2.967

7.  Role of antiviral therapy in reducing recurrence and improving survival in hepatitis B virus-associated hepatocellular carcinoma following curative resection (Review).

Authors:  Chaohui Zuo; Man Xia; Qunfeng Wu; Haizhen Zhu; Jingshi Liu; Chen Liu
Journal:  Oncol Lett       Date:  2014-11-21       Impact factor: 2.967

8.  Risk Factors and Post-Resection Independent Predictive Score for the Recurrence of Hepatitis B-Related Hepatocellular Carcinoma.

Authors:  Ivan Fan-Ngai Hung; Danny Ka-Ho Wong; Ronnie Tung-Ping Poon; Daniel Yee-Tak Fong; Ada Hang-Wai Chui; Wai-Kay Seto; James Yan-Yue Fung; Albert Chi-Yan Chan; John Chi-Hang Yuen; Randal Tiu; Olivia Choi; Ching-Lung Lai; Man-Fung Yuen
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

9.  Nuclear Expression of Hepatitis B Virus X Protein Is Associated with Recurrence of Early-Stage Hepatocellular Carcinomas: Role of Viral Protein in Tumor Recurrence.

Authors:  Jing Jin; Hae Yoen Jung; Kyu Ho Lee; Nam-Joon Yi; Kyung-Suk Suh; Ja-June Jang; Kyoung-Bun Lee
Journal:  J Pathol Transl Med       Date:  2016-04-17

10.  Feasibility and Efficacy of S-Adenosyl-L-methionine in Patients with HBV-Related HCC with Different BCLC Stages.

Authors:  Tao Guo; Yukun He; Weijie Ma; Zhisu Liu; Quanyan Liu
Journal:  Gastroenterol Res Pract       Date:  2016-11-28       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.